Candel Therapeutics, Inc. (CADL)
Data as of , from SEC Form 4 filings.
See up to 3 months of CADL. The 7-day demo opens the 1M and 3M ranges and puts CADL on your watchlist.
Start 7-day demoLatest CADL insider trades
About Candel Therapeutics, Inc. (CADL)
The SEC lists Candel Therapeutics, Inc. under CIK 0001841387, in biological products (no diagnostic substances). We track it alongside the rest of the Health Care sector.
CADL Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 3 | 287,245 | $3.24M |
| Grant or award | 4 | 67,894 | |
| Option exercise | 2 | 250,000 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
CADL insider transactions (Form 4)
5650 Form 4 filings on record, the earliest from Oct 3, 2024, newest first. Filing history page 2 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| William Garrett Nichols - Officer | Option exercise | Common Stock | 937 | $1.29 | $1K | |
| William Garrett Nichols - Officer | Open-market sale | Common Stock | 937 | $6.98 | $7K | |
| William Garrett Nichols - Officer | Option exercise | Stock Option (Right to Buy) | 937 | $0.00 | - | |
| William Garrett Nichols - Officer | Option exercise | Common Stock | 781 | $1.29 | $1K | |
| William Garrett Nichols - Officer | Open-market sale | Common Stock | 781 | $5.04 | $4K | |
| William Garrett Nichols - Officer | Option exercise | Stock Option (Right to Buy) | 781 | $0.00 | - | |
 Joseph C. Papa | Grant or award | Common Stock | 64,239 | $4.67 | $300K | |
| Joseph C. Papa | Grant or award | Stock Option (Right to Buy) | 14,240 | $0.00 | - | |
| Estuardo Aguilar-Cordova - 10% Owner | Derivative | CADL | 50,000 | $9.01 | $451K | |
| Estuardo Aguilar-Cordova - 10% Owner | Derivative | CADL | 50,000 | $9.01 | $451K | |
| Estuardo Aguilar-Cordova - 10% Owner | Derivative | CADL | 50,000 | $8.85 | $443K | |
| Estuardo Aguilar-Cordova - 10% Owner | Derivative | CADL | 50,000 | $8.85 | $443K | |
| Estuardo Aguilar-Cordova - 10% Owner | Derivative | CADL | 100,000 | $9.00 | $900K | |
| Estuardo Aguilar-Cordova - 10% Owner | Derivative | CADL | 100,000 | $9.00 | $900K | |
| Estuardo Aguilar-Cordova - 10% Owner | Derivative | CADL | 50,000 | $8.52 | $426K | |
| Estuardo Aguilar-Cordova - 10% Owner | Derivative | CADL | 50,000 | $8.52 | $426K | |
| Estuardo Aguilar-Cordova - 10% Owner | Derivative | CADL | 50,000 | $8.82 | $441K | |
| Estuardo Aguilar-Cordova - 10% Owner | Derivative | CADL | 50,000 | $8.82 | $441K | |
 Paul B. Manning | Open-market purchase | Common Stock | 500,000 | $6.00 | $3.00M | |
| Paul B. Manning | Open-market purchase | Common Stock | 750,000 | $6.00 | $4.50M | |
| Estuardo Aguilar-Cordova - 10% Owner | Derivative | CADL | 200,000 | $8.53 | $1.71M | |
| Estuardo Aguilar-Cordova - 10% Owner | Derivative | CADL | 200,000 | $8.53 | $1.71M | |
| Estuardo Aguilar-Cordova - 10% Owner | Derivative | CADL | 200,000 | $10.04 | $2.01M | |
| Estuardo Aguilar-Cordova - 10% Owner | Derivative | CADL | 200,000 | $10.04 | $2.01M | |
| Estuardo Aguilar-Cordova - 10% Owner | Derivative | CADL | 20,000 | $4.46 | $89K | |
| Estuardo Aguilar-Cordova - 10% Owner | Derivative | CADL | 20,000 | $4.79 | $96K | |
| Estuardo Aguilar-Cordova - 10% Owner | Derivative | CADL | 20,000 | $5.23 | $105K | |
| Seshu Tyagarajan - Officer | Open-market sale | Common Stock | 20,392 | $4.56 | $93K | |
| Paul Peter Tak - Officer | Open-market sale | Common Stock | 48,847 | $4.56 | $223K | |
| Francesca Barone - Officer | Open-market sale | Common Stock | 22,081 | $4.56 | $101K | |
| William Garrett Nichols - Officer | Open-market sale | Common Stock | 13,935 | $4.56 | $63K | |
| Estuardo Aguilar-Cordova - 10% Owner | Derivative | CADL | 20,000 | $4.97 | $99K | |
| Paul Peter Tak - Officer | Option exercise | Common Stock | 12,900 | $1.55 | $20K | |
| Paul Peter Tak - Officer | Option exercise | Stock Option (Right to Buy) | 12,900 | $0.00 | - | |
| Estuardo Aguilar-Cordova - 10% Owner | Derivative | CADL | 7,500 | $5.33 | $40K | |
| Estuardo Aguilar-Cordova - 10% Owner | Derivative | CADL | 7,500 | $5.33 | $40K | |
| Estuardo Aguilar-Cordova - 10% Owner | Derivative | CADL | 7,500 | $5.19 | $39K | |
| Estuardo Aguilar-Cordova - 10% Owner | Derivative | CADL | 7,500 | $5.19 | $39K | |
| Estuardo Aguilar-Cordova - 10% Owner | Derivative | CADL | 7,500 | $4.92 | $37K | |
| Estuardo Aguilar-Cordova - 10% Owner | Derivative | CADL | 7,500 | $4.92 | $37K | |
| Estuardo Aguilar-Cordova - 10% Owner | Derivative | CADL | 6,000 | $5.38 | $32K | |
| Estuardo Aguilar-Cordova - 10% Owner | Derivative | CADL | 6,000 | $5.38 | $32K | |
| Estuardo Aguilar-Cordova - 10% Owner | Derivative | CADL | 7,500 | $5.30 | $40K | |
| Estuardo Aguilar-Cordova - 10% Owner | Derivative | CADL | 7,500 | $5.30 | $40K | |
| Estuardo Aguilar-Cordova - 10% Owner | Derivative | CADL | 7,500 | $5.27 | $40K | |
| Estuardo Aguilar-Cordova - 10% Owner | Derivative | CADL | 7,500 | $5.27 | $40K | |
| Estuardo Aguilar-Cordova - 10% Owner | Derivative | CADL | 16,427 | $5.53 | $91K | |
| Estuardo Aguilar-Cordova - 10% Owner | Derivative | CADL | 1,194 | $5.72 | $7K | |
| Estuardo Aguilar-Cordova - 10% Owner | Derivative | CADL | 1,597 | $5.80 | $9K | |
| Estuardo Aguilar-Cordova - 10% Owner | Derivative | CADL | 11,711 | $5.58 | $65K | |
| Estuardo Aguilar-Cordova - 10% Owner | Open-market sale | CADL | 15,000 | $6.05 | $91K | |
| Estuardo Aguilar-Cordova - 10% Owner | Open-market sale | CADL | 15,000 | $6.02 | $90K | |
| Estuardo Aguilar-Cordova - 10% Owner | Open-market sale | CADL | 10,412 | $6.03 | $63K | |
| Estuardo Aguilar-Cordova - 10% Owner | Open-market sale | CADL | 6,214 | $7.01 | $44K | |
| Estuardo Aguilar-Cordova - 10% Owner | Open-market sale | CADL | 26,988 | $6.92 | $187K | |
| Estuardo Aguilar-Cordova - 10% Owner | Open-market sale | CADL | 1,800 | $6.85 | $12K |
Recent CADL Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| PAUL PETER TAK | Director, Officer | 280,245 | $3.41M | View on EDGAR | |
| SESHU TYAGARAJAN | Officer | 7,000 |
CADL insider trading FAQ
What is the latest insider trade for CADL?
Candel Therapeutics, Inc. (CADL) had 6 insider filings in the last 90 days, with the most recent on 2026-10-02. The full record for CADL runs to 50 Form 4 filings, the earliest from 2024-10-03. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying CADL stock?
No insider purchases of CADL were filed in the last 90 days. 3 purchases are on record for this company.
How many insiders are selling CADL stock?
3 insider sales of CADL were filed in the last 90 days, totaling $3.24M.
Where can I see CADL SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects CADL Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Nicoletta Loggia view on EDGAR
- - Joseph C. Papa view on EDGAR
- - Paul B. Manning view on EDGAR
- - Paul Peter Tak view on EDGAR
- - Martine Zimmermann view on EDGAR
- - Seshu Tyagarajan view on EDGAR
- - Mark E. Sims view on EDGAR
- - Francesca Barone view on EDGAR
- - Seshu Tyagarajan view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where CADL's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow CADL with a 7-day demo
- CADL on your watchlist
- Every CADL Form 4 filing on record
- Up to 3 months of CADL price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
